MATILDE regimen

chemotherapy protocol consisting of above cpds for treatment of primary CNS lymphomas

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - MATILDE regimen: 2
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - MATILDE regimen: 2
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - MATILDE regimen: 2
Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 521
    - Pyrimidine Nucleosides: 50
      - Cytidine: 548
        Cytarabine: 6746
        MATILDE regimen: 2
  - Azirines
    - Aziridines: 14
      - Triethylenephosphoramide: 79
        Thiotepa: 1150
        MATILDE regimen: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Pteridines: 149
      - Pterins: 156
        Aminopterin: 244
        Methotrexate: 24421
        MATILDE regimen: 2
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6937
  - Pyrimidine Nucleosides: 50
    - Cytidine: 548
      - Cytarabine: 6746
        MATILDE regimen: 2
  - Arabinonucleosides: 1
    - Cytarabine: 6746
      - MATILDE regimen: 2
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthacenes
        Anthracyclines: 9615
        Daunorubicin: 2659
        Idarubicin: 932
        MATILDE regimen: 2
- Organophosphorus Compounds: 307
  - Phosphoramides: 8
    - Thiotepa: 1150
      - MATILDE regimen: 2
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthacenes
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Idarubicin: 932
        MATILDE regimen: 2
Carbohydrates: 22516
- Glycosides: 2186
  - Aminoglycosides: 5203
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Idarubicin: 932
        MATILDE regimen: 2

F Caligaris Cappio Selected Research

F Caligaris Cappio Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure